Developing a vaccine for pandemic and pre-emergent coronaviruses
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
This study is working on a new vaccine to help protect people from current and future coronavirus outbreaks, so that if successful, it could keep you safe from getting really sick during these times.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10710595 on NIH RePORTER |
What this research studies
This research focuses on creating a vaccine that can be used in response to outbreaks of coronaviruses, including those that may emerge in the future. The approach involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating the vaccine's effectiveness and safety through animal studies. If successful, this vaccine could provide critical protection against infectious diseases that pose a threat to public health. Patients may benefit from the eventual availability of a vaccine that can prevent severe illness during outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for exposure to coronaviruses, such as healthcare workers and those in outbreak-prone areas.
Not a fit: Patients who are not at risk for exposure to coronaviruses or those who have already been vaccinated against similar viruses may not receive benefit from this research.
Why it matters
Potential benefit: This research could lead to the development of a vaccine that protects against severe illness from emerging coronaviruses.
How similar studies have performed: Other research has shown success in developing vaccines for infectious diseases, indicating that this approach has the potential for significant impact.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Saunders, Kevin — Duke University
- Study coordinator: Saunders, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.